| Statement Reflects Principles and Methods of CER |
Clinician Type |
| Physician |
Physician Assistant |
Nurse Practitioner |
Total |
| Freq. |
Percent |
Freq. |
Percent |
Freq. |
Percent |
Freq. |
Percent |
| CER Knowledge Score |
| Mean |
5.36 |
|
4.83 |
|
5.45 |
|
5.23 |
5.36 |
| Standard Deviation |
2.72 |
|
2.56 |
|
2.40 |
|
2.57 |
2.72 |
| N |
244 |
|
233 |
|
269 |
|
746 |
244 |
| 19a. Compares effectiveness and risks of established and emerging treatments |
| Yes |
190 |
78.2 |
174 |
75.3 |
216 |
80.6 |
580 |
78.2 |
| No |
7 |
2.9 |
6 |
2.6 |
8 |
3 |
21 |
2.8 |
| Not Sure |
46 |
18.9 |
51 |
22.1 |
44 |
16.4 |
141 |
19 |
| Total |
243 |
100 |
231 |
100 |
268 |
100 |
742 |
100 |
| 19b. Addresses treatments for common chronic medical conditions |
| Yes |
166 |
68.3 |
156 |
67.2 |
196 |
74.2 |
518 |
70.1 |
| No |
8 |
3.3 |
8 |
3.4 |
13 |
4.9 |
29 |
3.9 |
| Not Sure |
69 |
28.4 |
68 |
29.3 |
55 |
20.8 |
192 |
26 |
| Total |
243 |
100 |
232 |
100 |
264 |
100 |
739 |
100 |
| 19c. Includes reviews of existing scientific literature |
| Yes |
188 |
77.4 |
174 |
75.3 |
208 |
77.6 |
570 |
76.8 |
| No |
4 |
1.6 |
2 |
0.9 |
6 |
2.2 |
12 |
1.6 |
| Not Sure |
51 |
21 |
55 |
23.8 |
54 |
20.1 |
160 |
21.6 |
| Total |
243 |
100 |
231 |
100 |
268 |
100 |
742 |
100 |
| 19d. Includes new studies based on analyses of health care databases |
| Yes |
142 |
58.7 |
108 |
47 |
143 |
53.8 |
393 |
53.5 |
| No |
9 |
3.7 |
14 |
6.1 |
12 |
4.5 |
35 |
4.7 |
| Not Sure |
91 |
37.6 |
108 |
47 |
111 |
41.7 |
310 |
42 |
| Total |
242 |
100 |
230 |
100 |
266 |
100 |
738 |
100 |
| 19e. Includes new studies testing efficacy of new treatments/technologies |
| Yes |
136 |
56.2 |
112 |
48.5 |
155 |
58.1 |
4.3 |
54.5 |
| No |
22 |
9.1 |
22 |
9.5 |
19 |
7.1 |
63 |
8.5 |
| Not Sure |
84 |
34.7 |
97 |
42 |
93 |
34.8 |
274 |
37 |
| Total |
242 |
100 |
231 |
100 |
267 |
100 |
740 |
100 |
| 19f. Is conducted by pharmaceutical companies and medical device manufacturers |
| Yes |
41 |
16.9 |
34 |
14.7 |
41 |
15.6 |
116 |
15.8 |
| No |
63 |
26 |
50 |
21.6 |
64 |
24.3 |
177 |
24 |
| Not Sure |
138 |
57 |
147 |
63.6 |
158 |
60.1 |
443 |
60.2 |
| Total |
242 |
100 |
231 |
100 |
263 |
100 |
736 |
100 |
| 19g. Intended to support informed decisionmaking |
| Yes |
190 |
78.2 |
171 |
75 |
219 |
82 |
580 |
78.6 |
| No |
5 |
2.1 |
3 |
1.3 |
6 |
2.2 |
14 |
1.9 |
| Not Sure |
48 |
19.8 |
54 |
23.7 |
42 |
15.7 |
144 |
19.5 |
| Total |
243 |
100 |
228 |
100 |
267 |
100 |
738 |
10 |
| 19h. Addresses treatments for acute medical conditions |
| Yes |
137 |
56.6 |
106 |
46.7 |
141 |
53.8 |
384 |
52.5 |
| No |
18 |
7.4 |
17 |
7.5 |
24 |
9.2 |
59 |
8.1 |
| Not Sure |
87 |
36 |
104 |
45.8 |
97 |
37 |
288 |
39.4 |
| Total |
242 |
100 |
227 |
100 |
262 |
100 |
731 |
100 |
| 19i. Identifies areas of clinical uncertainty and gaps in scientific literature |
| Yes |
116 |
48.1 |
90 |
39.5 |
133 |
50.4 |
339 |
46.2 |
| No |
27 |
11.2 |
15 |
6.6 |
17 |
6.4 |
59 |
8 |
| Not Sure |
98 |
40.7 |
123 |
53.9 |
114 |
43.2 |
335 |
45.7 |
| Total |
241 |
100 |
228 |
100 |
264 |
100 |
733 |
100 |
| 19j. Intended to assist in shared decisionmaking between clinicians and patients |
| Yes |
179 |
73.4 |
140 |
61.1 |
199 |
75.1 |
518 |
70.2 |
| No |
7 |
2.9 |
9 |
3.9 |
7 |
2.6 |
23 |
3.1 |
| Not Sure |
58 |
23.8 |
80 |
34.9 |
59 |
22.3 |
197 |
26.7 |
| Total |
244 |
100 |
229 |
100 |
265 |
100 |
738 |
100 |
| 19k. Provides specific clinical practice recommendations for medical conditions |
| Yes |
106 |
44 |
95 |
41.7 |
123 |
46.4 |
324 |
44.1 |
| No |
35 |
14.5 |
23 |
10.1 |
44 |
16.6 |
102 |
13.9 |
| Not Sure |
100 |
41.5 |
110 |
48.2 |
98 |
37 |
308 |
42 |
| Total |
241 |
100 |
228 |
100 |
265 |
100 |
734 |
100 |
| Statement Describes the EHC Program |
Clinician Type |
| Physician |
Physician Assistant |
Nurse Practitioner |
Total |
| Freq. |
Percent |
Freq. |
Percent |
Freq. |
Percent |
Freq. |
Percent |
| EHC Program Knowledge Score |
| Mean |
6.02 |
|
6.07 |
|
6.61 |
|
6.32 |
6.02 |
| Standard Deviation |
3.70 |
|
3.13 |
|
2.48 |
|
3.00 |
3.70 |
| N |
49 |
|
44 |
|
90 |
|
183 |
49 |
| 26a. Is co-sponsored by private health care and medical technology firms |
| Yes |
8 |
16.3 |
10 |
23.3 |
15 |
16.7 |
33 |
18.1 |
| No |
10 |
20.4 |
12 |
30.2 |
28 |
31.1 |
51 |
28 |
| Not Sure |
31 |
63.3 |
20 |
46.5 |
47 |
52.2 |
98 |
53.8 |
| Total |
49 |
100 |
43 |
100 |
90 |
100 |
182 |
100 |
| 26b. Funds and conducts comparative effectiveness research in the U.S. |
| Yes |
35 |
72.9 |
40 |
90.9 |
76 |
84.4 |
151 |
83 |
| No |
1 |
2.1 |
0 |
0 |
1 |
1.1 |
2 |
1.1 |
| Not Sure |
12 |
25 |
4 |
9.1 |
13 |
14.4 |
29 |
15.9 |
| Total |
48 |
100 |
44 |
100 |
90 |
100 |
182 |
100 |
| 26c. Funds the development of new treatments |
| Yes |
10 |
20.4 |
9 |
20.9 |
33 |
36.7 |
52 |
28.6 |
| No |
23 |
46.9 |
13 |
30.2 |
27 |
30 |
63 |
34.6 |
| Not Sure |
16 |
32.7 |
21 |
48.8 |
30 |
33.3 |
67 |
36.8 |
| Total |
49 |
100 |
43 |
100 |
90 |
100 |
182 |
100 |
| 26d. Screens all sponsored researchers for conflicts of interest |
| Yes |
25 |
51 |
26 |
60.5 |
63 |
70 |
114 |
62.6 |
| No |
2 |
4.1 |
0 |
0 |
1 |
1.1 |
3 |
1.6 |
| Not Sure |
22 |
44.9 |
17 |
39.5 |
26 |
28.9 |
65 |
35.7 |
| Total |
49 |
100 |
43 |
100 |
90 |
100 |
182 |
100 |
| 26e. All reports are posted for public comment |
| Yes |
25 |
52.1 |
20 |
46.5 |
47 |
52.2 |
92 |
50.8 |
| No |
3 |
6.3 |
3 |
7 |
4 |
4.4 |
10 |
5.5 |
| Not Sure |
20 |
41.7 |
20 |
46.5 |
39 |
43.3 |
79 |
43.6 |
| Total |
48 |
100 |
43 |
100 |
90 |
100 |
181 |
100 |
| 26f. All reports are peer reviewed |
| Yes |
29 |
61.7 |
27 |
62.8 |
60 |
68.2 |
116 |
65.2 |
| No |
3 |
6.4 |
1 |
2.3 |
1 |
1.1 |
5 |
2.8 |
| Not Sure |
15 |
31.9 |
15 |
34.9 |
27 |
30.7 |
57 |
32 |
| Total |
47 |
100 |
43 |
100 |
88 |
100 |
178 |
100 |
| 26g. Is sponsored by the Agency for Healthcare Research and Quality (AHRQ) |
| Yes |
39 |
83 |
33 |
75 |
79 |
87.8 |
151 |
83.4 |
| No |
0 |
0 |
2 |
4.5 |
1 |
1.1 |
3 |
1.7 |
| Not Sure |
8 |
17 |
9 |
20.5 |
10 |
11.1 |
27 |
14.9 |
| Total |
47 |
100 |
44 |
100 |
90 |
100 |
181 |
100 |
| 26h. Open for public participation |
| Yes |
22 |
46.8 |
16 |
38.1 |
38 |
42.7 |
76 |
42.7 |
| No |
2 |
4.3 |
4 |
9.5 |
8 |
9 |
14 |
7.9 |
| Not Sure |
23 |
48.9 |
22 |
52.4 |
43 |
48.3 |
88 |
49.4 |
| Total |
47 |
100 |
42 |
100 |
89 |
100 |
178 |
100 |
| 26i. Uses transparent and clearly documented processes |
| Yes |
32 |
69.6 |
25 |
59.5 |
66 |
73.3 |
123 |
69.1 |
| No |
2 |
4.3 |
2 |
4.8 |
3 |
3.3 |
7 |
3.9 |
| Not Sure |
12 |
26.1 |
15 |
35.7 |
21 |
23.3 |
48 |
27 |
| Total |
46 |
100 |
42 |
100 |
90 |
100 |
178 |
100 |
| 26j. Includes clinicians as a target audience for research results |
| Yes |
33 |
67.3 |
35 |
79.5 |
68 |
75.6 |
136 |
74.3 |
| No |
2 |
4.1 |
0 |
0 |
7 |
7.8 |
9 |
4.9 |
| Not Sure |
14 |
28.6 |
9 |
20.5 |
15 |
16.7 |
38 |
20.8 |
| Total |
49 |
100 |
44 |
100 |
90 |
100 |
183 |
100 |
| 26k. Includes consumers/patients as a target audience for research results |
| Yes |
26 |
56.5 |
23 |
53.5 |
59 |
65.6 |
108 |
60.3 |
| No |
2 |
4.3 |
2 |
4.7 |
6 |
6.7 |
10 |
5.6 |
| Not Sure |
18 |
39.1 |
18 |
41.9 |
25 |
27.8 |
61 |
34.1 |
| Total |
46 |
100 |
43 |
100 |
90 |
100 |
179 |
100 |
| 26l. Includes policymakers as a target audience for research results |
| Yes |
22 |
46.8 |
22 |
51.2 |
43 |
47.8 |
87 |
48.3 |
| No |
1 |
2.1 |
3 |
7 |
10 |
11.1 |
14 |
7.8 |
| Not Sure |
24 |
51.1 |
18 |
41.9 |
37 |
41.1 |
79 |
43.9 |
| Total |
47 |
100 |
43 |
100 |
90 |
100 |
180 |
100 |
| Comparative effectiveness research... |
Clinician Type |
| Physician |
Physician Assistant |
Nurse Practitioner |
Total |
| Freq. |
Percent |
Freq. |
Percent |
Freq. |
Percent |
Freq. |
Percent |
| CER Knowledge Score |
| Mean |
0.54 |
|
0.52 |
|
0.61 |
|
0.56 |
0.54 |
| Standard Deviation |
0.60 |
|
0.46 |
|
0.52 |
|
0.53 |
0.60 |
| N |
241 |
|
234 |
|
268 |
|
743 |
241 |
| 20a. Is neutral and unbiased |
| Strongly disagree |
4 |
1.7 |
2 |
0.9 |
2 |
0.8 |
8 |
1.1 |
| Disagree |
12 |
5 |
13 |
5.6 |
18 |
6.8 |
43 |
5.8 |
| Neither agree nor disagree |
106 |
44.4 |
113 |
48.7 |
117 |
44.2 |
336 |
45.7 |
| Agree |
102 |
42.7 |
92 |
39.7 |
107 |
40.4 |
301 |
40.9 |
| Strongly agree |
15 |
6.3 |
12 |
5.2 |
21 |
7.9 |
48 |
6.5 |
| Total |
239 |
100 |
232 |
100 |
265 |
100 |
736 |
100 |
| 20b. Is scientifically rigorous |
| Strongly disagree |
6 |
2.5 |
2 |
0.9 |
1 |
0.4 |
9 |
1.2 |
| Disagree |
11 |
4.6 |
8 |
3.4 |
9 |
3.4 |
28 |
3.8 |
| Neither agree nor disagree |
89 |
37.2 |
107 |
46.1 |
100 |
37.9 |
296 |
40.3 |
| Agree |
117 |
49 |
100 |
43.1 |
129 |
48.9 |
346 |
47.1 |
| Strongly agree |
16 |
6.7 |
15 |
6.5 |
25 |
9.5 |
56 |
7.6 |
| Total |
239 |
100 |
232 |
100 |
264 |
100 |
735 |
100 |
| 20c. Provides findings that are descriptive, not prescriptive |
| Strongly disagree |
6 |
2.5 |
1 |
0.4 |
2 |
0.8 |
9 |
1.2 |
| Disagree |
10 |
4.2 |
6 |
2.6 |
7 |
2.7 |
23 |
3.1 |
| Neither agree nor disagree |
97 |
40.9 |
119 |
51.3 |
107 |
40.5 |
323 |
44.1 |
| Agree |
114 |
48.1 |
97 |
41.8 |
130 |
49.2 |
341 |
46.5 |
| Strongly agree |
10 |
4.2 |
9 |
3.9 |
18 |
6.8 |
37 |
5 |
| Total |
237 |
100 |
232 |
100 |
264 |
100 |
733 |
100 |
| 20d. Provides objective info about drugs, medical equipment, and treatments |
| Strongly disagree |
5 |
2.1 |
2 |
0.9 |
2 |
0.8 |
9 |
1.2 |
| Disagree |
8 |
3.3 |
5 |
2.1 |
8 |
3 |
21 |
2.8 |
| Neither agree nor disagree |
74 |
30.8 |
87 |
37.3 |
98 |
37 |
259 |
35.1 |
| Agree |
134 |
55.8 |
129 |
55.4 |
134 |
50.6 |
397 |
53.8 |
| Strongly agree |
19 |
7.9 |
10 |
4.3 |
23 |
8.7 |
52 |
7 |
| Total |
240 |
100 |
233 |
100 |
265 |
100 |
738 |
100 |
| 20e. Provides findings that support informed decisionmaking |
| Strongly disagree |
8 |
3.3 |
1 |
0.4 |
2 |
0.8 |
11 |
1.5 |
| Disagree |
1 |
0.4 |
0 |
0 |
1 |
0.4 |
2 |
0.3 |
| Neither agree nor disagree |
54 |
22.4 |
71 |
30.6 |
64 |
24.1 |
189 |
25.6 |
| Agree |
145 |
60.2 |
141 |
60.8 |
162 |
60.9 |
448 |
60.6 |
| Strongly agree |
33 |
13.7 |
19 |
8.2 |
37 |
13.9 |
89 |
12 |
| Total |
241 |
100 |
232 |
100 |
266 |
100 |
739 |
100 |
| 20f. Highlights current evidence about effectiveness, risks, and side effects |
| Strongly disagree |
7 |
2.9 |
1 |
0.4 |
2 |
0.7 |
10 |
1.3 |
| Disagree |
3 |
1.2 |
0 |
0 |
3 |
1.1 |
6 |
0.8 |
| Neither agree nor disagree |
57 |
23.7 |
69 |
29.5 |
69 |
25.8 |
195 |
26.3 |
| Agree |
140 |
58.1 |
146 |
62.4 |
151 |
56.6 |
437 |
58.9 |
| Strongly agree |
34 |
14.1 |
18 |
7.7 |
42 |
15.7 |
94 |
12.7 |
| Total |
241 |
100 |
234 |
100 |
267 |
100 |
742 |
100 |
| 20g. Identifies areas of clinical uncertainty and gaps in scientific literature |
| Strongly disagree |
6 |
2.5 |
1 |
0.4 |
2 |
0.8 |
9 |
1.2 |
| Disagree |
14 |
5.9 |
13 |
5.6 |
14 |
5.3 |
41 |
5.6 |
| Neither agree nor disagree |
91 |
38.1 |
127 |
54.5 |
117 |
44.3 |
335 |
45.5 |
| Agree |
106 |
44.4 |
84 |
36.1 |
109 |
41.3 |
299 |
40.6 |
| Strongly agree |
22 |
9.2 |
8 |
3.4 |
22 |
8.3 |
52 |
7.1 |
| Total |
239 |
100 |
233 |
100 |
264 |
100 |
736 |
100 |
| 20h. Includes confidence ratings on evidence in reports, products, and materials |
| Strongly disagree |
6 |
2.5 |
1 |
0.4 |
3 |
1.1 |
10 |
1.4 |
| Disagree |
12 |
5.1 |
9 |
3.9 |
17 |
6.4 |
38 |
5.2 |
| Neither agree nor disagree |
138 |
58.2 |
147 |
63.4 |
164 |
61.9 |
449 |
61.2 |
| Agree |
70 |
29.5 |
69 |
29.7 |
71 |
26.8 |
210 |
28.6 |
| Strongly agree |
11 |
4.6 |
6 |
2.6 |
10 |
3.8 |
27 |
3.7 |
| Total |
237 |
100 |
232 |
100 |
265 |
100 |
734 |
100 |
| 20i. Helps me deliver better health care to my patients |
| Strongly disagree |
7 |
2.9 |
2 |
0.9 |
2 |
0.8 |
11 |
1.5 |
| Disagree |
5 |
2.1 |
3 |
1.3 |
3 |
1.1 |
11 |
1.5 |
| Neither agree nor disagree |
91 |
37.8 |
97 |
41.6 |
96 |
36.1 |
284 |
38.4 |
| Agree |
122 |
50.6 |
113 |
48.5 |
133 |
50 |
368 |
49.7 |
| Strongly agree |
16 |
6.6 |
18 |
7.7 |
32 |
12 |
66 |
8.9 |
| Total |
241 |
100 |
233 |
100 |
266 |
100 |
740 |
100 |
| 20j. In general, medical decisions based on CER lead to better patient outcomes |
| Strongly disagree |
7 |
2.9 |
2 |
0.9 |
1 |
0.4 |
10 |
1.3 |
| Disagree |
6 |
2.5 |
5 |
2.1 |
4 |
1.5 |
15 |
2 |
| Neither agree nor disagree |
116 |
48.3 |
112 |
47.9 |
106 |
39.7 |
334 |
45.1 |
| Agree |
95 |
39.6 |
100 |
42.7 |
123 |
46.1 |
318 |
42.9 |
| Strongly agree |
16 |
6.7 |
15 |
6.4 |
33 |
12.4 |
64 |
8.6 |
| Total |
240 |
100 |
234 |
100 |
267 |
100 |
741 |
100 |
| 20k. Medical decisions based on CER are more cost effective in the long run |
| Strongly disagree |
6 |
2.5 |
4 |
1.7 |
1 |
0.4 |
11 |
1.5 |
| Disagree |
11 |
4.6 |
9 |
3.9 |
14 |
5.3 |
34 |
4.6 |
| Neither agree nor disagree |
132 |
55 |
141 |
60.5 |
157 |
59.2 |
430 |
58.3 |
| Agree |
76 |
31.7 |
70 |
30 |
74 |
27.9 |
220 |
29.8 |
| Strongly agree |
15 |
6.3 |
9 |
3.9 |
19 |
7.2 |
43 |
5.8 |
| Total |
240 |
100 |
233 |
100 |
265 |
100 |
738 |
100 |
| 20l. Leads to shared decisionmaking between clinicians and individual patients |
| Strongly disagree |
7 |
2.9 |
2 |
0.9 |
1 |
0.4 |
10 |
1.3 |
| Disagree |
8 |
3.3 |
2 |
0.9 |
8 |
3 |
18 |
2.4 |
| Neither agree nor disagree |
90 |
37.5 |
100 |
42.7 |
85 |
31.8 |
275 |
37.1 |
| Agree |
121 |
50.4 |
118 |
50.4 |
148 |
55.4 |
387 |
52.2 |
| Strongly agree |
14 |
5.8 |
12 |
5.1 |
25 |
9.4 |
51 |
6.9 |
| Total |
240 |
100 |
234 |
100 |
267 |
100 |
740 |
100 |